CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,263
- in 2 filings
Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-24 | Lingnau Lutz Director | Exercise or conversion | +15,000 | $8.81 | $132K | 31,450 |
| 2014-11-24 | Lingnau Lutz Director | Sale | −15,000 | $15.02 | $225K | 16,450 |
| 2014-11-24 | Lingnau Lutz Director | Exercise or conversion · Stock Option | −15,000 | 0 | ||
| 2014-11-03 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion | +9,900 | $11.38 | $113K | 13,651 |
| 2014-11-03 | Labrucherie Gil M SVP & General Counsel | Sale | −9,900 | $13.78 | $136K | 3,751 |
| 2014-11-03 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion · Stock Option | −9,900 | 0 | ||
| 2014-09-23 | Krivulka Joseph J Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | WINGER DENNIS L Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | WHITFIELD ROY A Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | WANG SUSAN Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | Lingnau Lutz Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | KUEBLER CHRISTOPHER A Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | GREER R SCOTT Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-09-23 | CHESS ROBERT Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2014-05-19 | Gergel Ivan P. SVP Drug Development & CMO | Grant or award · Employee Stock Option | +550,000 | 550,000 | ||
| 2014-02-05 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +42,500 | 42,500 | ||
| 2014-02-05 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +42,500 | 42,500 | ||
| 2014-02-05 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2014-02-05 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2014-02-05 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +87,500 | 87,500 |
Page 66 of 69 · 1,361 trades